Get in touch
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.
Contact usTrilateral Research is a UK based enterprise, founded in 2004. Their rigorous research is at the foundation of their work.
);Myriad worked with us
Myriad worked with us to really pinpoint our innovation and make our Innovate UK application much more specific in terms of what the main selling point was and making it stand out from the crowd
Trilateral Research is a UK based enterprise, founded in 2004. Their rigorous research is at the foundation of their work.
They provide regulatory and policy advice; develop new data-driven technologies and contribute to the latest standards in safeguarding privacy, ethics and human rights within the public and private sector.
Their teams collaborate across the technology-social disciplinary divide, being able to assess the impact of emerging technologies to avoid adverse and unwanted consequences while delivering sustainable innovation.
They focus their efforts on areas where the application of research can make a difference in enhancing societal well-being.
As a business, Trilateral Research has been involved in grant bid writing for over 10 years, primarily within the Horizon 2020 domain.
Hayley Watson, Practice Manager at Trilateral, reached out to Myriad Associates as they were looking for a bid writer to support a different type of funding activity, Innovate UK.
"Because we weren’t used to bidding for Innovate UK grant funds, we were looking for a company that could help us put together a winning application. I came across Myriad predominantly as a result of a Google search, and had a preliminary conversation with Barrie and it went from there"
Myriad were quick to add value to Trilateral's internal grant bid writing skill set and worked collaboratively with the Trilateral team to get their grant application to a place where Myriad felt it would likely win funding.
"I think the concept and the approach that we were taking on our own was a little bit too broad and Marc had warned us of that. Marc worked with me and the rest of the team directly in order to really pinpoint our innovation and get it to a much more specific point in terms of what the main selling point was that we had to offer, where the innovation was coming from and basically making it stand out from the crowd. I think Marc was excellent in getting the information out of us that he needed in order to do that."
The reward of Myriad & Trilateral's collaborative approach led to Trilateral being awarded an Innovate UK grant to the value of £499,725.
When asked whether Hayley would recommend Myriad Associates; "Yes, absolutely, no question. I think we’re likely to be drawing on Myriad again in the future ourselves. Marc was very engaged and in tune with the way that the group was working and was able to act as a bit of a mediator in terms of different lines of thought within our own group, and I think that was a really important element that he could facilitate conversations and get out of each of us what he needed to get the different components of the proposal done"
What 3 words would Hayley use to describe her experience with Myriad;
"I’d say ‘professional’ ‘patient’ and ‘collaborative,’ which for me was really important. As a bid writer myself, I needed to be able to work with somebody, not have somebody just tell me what to do. So, I enjoyed that component of things"
ONK Therapeutics was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
R&D GrantsPlease contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.
Contact us